Related Experiment Videos
[Phenotypic characterization of human hematopoietic stem cells]
Wiener Medizinische Wochenschrift (1946)
|January 1, 1995
Summary
Hematopoietic stem cells identified by CD34 expression can be subdivided. This allows separation of immature multipotential cells from lineage-committed progenitors, aiding in understanding blood cell development.
Area of Science:
- Hematology
- Stem Cell Biology
- Immunophenotyping
Context:
- Mature blood cells originate from progenitor cells, which are derived from pluripotential stem cells.
- In vitro clonogenic assays have identified distinct progenitor cell stages.
- The CD34 molecule is expressed on all in vitro clonogenic cells within bone marrow and peripheral blood.
Purpose:
- To identify and separate distinct subsets of hematopoietic progenitor cells based on immunophenotypic markers.
- To differentiate between immature multipotential clonogenic cells and lineage-committed colony-forming cells.
- To characterize molecules involved in early lineage commitment and cell-stroma interactions.
Summary:
- CD34-positive cells, representing all in vitro clonogenic cells, can be further subdivided using coexpressed molecules.
- Immunophenotypic analysis allows separation of multipotential progenitors from committed progenitors.
- Specific molecules identify early granulomonocytic, erythroid, and lymphoid differentiation stages and mediate cell-stroma interactions.
Impact:
- Enables precise isolation of specific hematopoietic progenitor cell populations for further study.
- Facilitates a deeper understanding of normal hematopoiesis and early lineage commitment.
- Provides insights into the molecular mechanisms governing stem cell interactions with their microenvironment.